BM
Ben Manderman
Executive Medical Director Oncology Lead Europe at Pharm Olam,
View Ben's Contact Info for Free. Sign Up and Get 50 Free Contacts Per Month.Get Started for Free
Work Experience
Executive Medical Director Oncology Lead Europe
Oct 2020 - Present · 4 years and 3 months
IQVIA Biotech
Sr Medical Director Oncology Eu
Feb 2019 - Oct 2020 · 1 years and 8 months
Senior Medical Director Eu
Jan 2017 - Feb 2019 · 2 years and 1 months
Company Details
501-1000 Employees
Pharm-Olam is now Allucent. Purpose-built through the convergence of several leading providers including Pharm-Olam, Allucent is a global provider of comprehensive drug development solutions for small to mid-sized biotech companies across a variety of therapeutic areas. With more than 30 years of experience in over 60 countries, Allucent’s individualized partnership approach provides experience-driven insights and expertise in early and late-stage development including consulting, clinical operations, biometrics, and clinical pharmacology.
Year Founded
1994
Social Media
Linkedin
Industry
Pharmaceutical Manufacturing
HQ Location
450 N. Sam Houston Pkwy. E Suite 250 Houston, TX 77060, US
Keywords
CROcontract researchpatient recruitmentregulatorymonitoringta managementpharmacovigilancephaseclinical trialpost-marketing surveillance
Discover More About Cleveland Clinic

Find verified contacts of Ben Manderman in seconds from 700M people profiles. Start now!

No Credit Card Needed. By signing up, you understand and agree to Futern's Terms and Policy.